14.65
price up icon1.88%   0.27
after-market Dopo l'orario di chiusura: 14.66 0.010 +0.07%
loading
Precedente Chiudi:
$14.38
Aprire:
$14.21
Volume 24 ore:
234.68K
Relative Volume:
0.97
Capitalizzazione di mercato:
$375.66M
Reddito:
-
Utile/perdita netta:
$11.77M
Rapporto P/E:
25.32
EPS:
0.5785
Flusso di cassa netto:
$-19.23M
1 W Prestazione:
+18.82%
1M Prestazione:
+5.24%
6M Prestazione:
-17.00%
1 anno Prestazione:
-64.94%
Intervallo 1D:
Value
$13.85
$14.78
Intervallo di 1 settimana:
Value
$12.34
$15.66
Portata 52W:
Value
$11.87
$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
Nome
Tourmaline Bio Inc
Name
Telefono
646-481-9832
Name
Indirizzo
27 WEST 24TH STREET, NEW YORK
Name
Dipendente
74
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
TRML's Discussions on Twitter

Confronta TRML con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TRML
Tourmaline Bio Inc
14.65 375.66M 0 11.77M -19.23M 0.5785
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.01 128.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
744.83 81.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
571.00 34.69B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.07 30.17B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.66 26.02B 3.32B -860.46M -1.04B -8.32

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-06 Iniziato Wedbush Outperform
2024-12-06 Iniziato BMO Capital Markets Outperform
2024-11-11 Reiterato H.C. Wainwright Buy
2023-12-15 Iniziato Jefferies Buy
2023-12-04 Ripresa H.C. Wainwright Buy
2023-11-17 Iniziato Truist Buy
2023-10-31 Iniziato Guggenheim Buy
2023-10-25 Iniziato Piper Sandler Overweight
2022-10-20 Iniziato H.C. Wainwright Buy
2022-07-05 Downgrade Morgan Stanley Overweight → Equal-Weight
Mostra tutto

Tourmaline Bio Inc Borsa (TRML) Ultime notizie

pulisher
Mar 10, 2025

Wedbush Forecasts Tourmaline Bio FY2024 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Tourmaline Bio (NASDAQ:TRML) Research Coverage Started at Wedbush - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Has $722,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Tourmaline Bio rises as Wedbush initiates with Outperform - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - NewsBreak

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Coverage on Tourmaline Bio With Outperform Rating, $42 Price Target - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target -March 06, 2025 at 07:22 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

We Tested Over 25 Curling Irons. These 13 Are the Best - MarieClaire.com

Mar 05, 2025
pulisher
Mar 03, 2025

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025 - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

3 Reasons to Buy American Express Stock Like There's No Tomorrow - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

When and Where to Catch Tourmaline Bio's Next Investor Presentation - StockTitan

Mar 03, 2025
pulisher
Feb 28, 2025

Brokers Set Expectations for Tourmaline Bio FY2024 Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Truist maintains $74 target on Tourmaline Bio stock, reiterates buy By Investing.com - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

Lifesci Capital Predicts Tourmaline Bio FY2024 Earnings - Armenian Reporter

Feb 27, 2025
pulisher
Feb 27, 2025

Financial Survey: X4 Pharmaceuticals (NASDAQ:XFOR) & Tourmaline Bio (NASDAQ:TRML) - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

Tourmaline Bio (NASDAQ:TRML) Coverage Initiated by Analysts at Lifesci Capital - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

LifeSci Capital Initiates Coverage of Tourmaline Bio (TRML) with Outperform Recommendation - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 24, 2025
pulisher
Feb 21, 2025

Vaxcyte (NASDAQ:PCVX) & Tourmaline Bio (NASDAQ:TRML) Financial Review - Defense World

Feb 21, 2025
pulisher
Feb 19, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $54.00 Average PT from Brokerages - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of “Buy” by Analysts - Defense World

Feb 19, 2025
pulisher
Feb 19, 2025

ClearOne (NASDAQ:CLRO) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 19, 2025
pulisher
Feb 19, 2025

StockNews.com Begins Coverage on Bank of South Carolina (NASDAQ:BKSC) - Defense World

Feb 19, 2025
pulisher
Feb 19, 2025

Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Short Interest Up 16.3% in January - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Vulcan Materials (VMC) Q4 Earnings: What To Expect - The Globe and Mail

Feb 17, 2025
pulisher
Feb 17, 2025

TrueBlue (TBI) Expected to Announce Earnings on Wednesday - Armenian Reporter

Feb 17, 2025
pulisher
Feb 16, 2025

Andersons (ANDE) Projected to Post Quarterly Earnings on Tuesday - Defense World

Feb 16, 2025
pulisher
Feb 13, 2025

Leerink Partnrs Comments on Tourmaline Bio FY2024 Earnings - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Leerink Partnrs Weighs in on Tourmaline Bio FY2029 Earnings - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Bleakley Financial Group LLC Purchases 110 Shares of Choice Hotels International, Inc. (NYSE:CHH) - Defense World

Feb 12, 2025
pulisher
Feb 11, 2025

In the crowded cardio space, it’s David vs. Goliath for small biotechs - PharmaVoice

Feb 11, 2025
pulisher
Feb 09, 2025

Jennison Associates LLC Trims Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Feb 09, 2025
pulisher
Feb 07, 2025

Tourmaline Bio Inc (TRML) Stock Showcases -13.66% 20-Day Moving Average - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

TRML’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Solventum Corp (SOLV) Shares Down Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 05, 2025

Tourmaline Bio Inc (TRML) Becoming More Attractive for Investors - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

In the Green: JBDI Holdings Ltd (JBDI) Closes at 0.65, Up/Down 11.02 from Previous Day - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Closing Bell Recap: E.W. Scripps Co (SSP) Ends at 1.88, Reflecting a 6.82 Upturn - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Post-Trade Analysis: Celldex Therapeutics Inc (CLDX) Slides -2.11, Closing at 23.15 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Market Insights: Avidity Biosciences Inc (RNA)’s Notable Gain of 4.32, Closing at 33.34 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Daily Market Movement: Tourmaline Bio Inc (TRML) Sees a 6.37 Increase, Closing at 16.53 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Keeping an Eye on Entegris Inc (ENTG) After Insider Trading Activity - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Potential Price Increase for Monster Beverage Corp (MNST) After Recent Insider Activity - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Recent Insider Activity Suggests Potential Gains for Vita Coco Company Inc (COCO) - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Rises By 26.8% - MarketBeat

Feb 04, 2025

Tourmaline Bio Inc Azioni (TRML) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$35.96
price up icon 0.98%
$21.98
price down icon 8.97%
$32.75
price down icon 0.79%
$317.87
price up icon 0.62%
$105.35
price down icon 3.15%
biotechnology ONC
$242.66
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):